Cargando…
Variation in Assignment of the COPD Patients into a GOLD Group According to Symptoms Severity
INTRODUCTION: The Global Organization of Lung Disease (GOLD) classifies patients with chronic obstructive pulmonary disease (COPD) taking into account the symptoms. The modified Medical Research Council’s dyspnea scale (mMRC) and the COPD assessment test (CAT) are used to assess these symptoms. In t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430767/ https://www.ncbi.nlm.nih.gov/pubmed/32848383 http://dx.doi.org/10.2147/COPD.S253445 |
_version_ | 1783571483720679424 |
---|---|
author | Moya-Álvarez, Virginia Quevedo-Marín, Juan Luis Ji, Zichen Navarro-Jiménez, Cristina Jiménez-García, Rodrigo López-de-Andrés, Ana Pérez-Trullén, Alfonso de Miguel-Díez, Javier |
author_facet | Moya-Álvarez, Virginia Quevedo-Marín, Juan Luis Ji, Zichen Navarro-Jiménez, Cristina Jiménez-García, Rodrigo López-de-Andrés, Ana Pérez-Trullén, Alfonso de Miguel-Díez, Javier |
author_sort | Moya-Álvarez, Virginia |
collection | PubMed |
description | INTRODUCTION: The Global Organization of Lung Disease (GOLD) classifies patients with chronic obstructive pulmonary disease (COPD) taking into account the symptoms. The modified Medical Research Council’s dyspnea scale (mMRC) and the COPD assessment test (CAT) are used to assess these symptoms. In this study, we analyze the concordance of GOLD classification using mMRC and CAT. PATIENTS AND METHODS: This is an observational study of a cohort of 169 patients with COPD, who were classified following the GOLD 2017 recommendations, using both mMRC and CAT. A concordance analysis was applied, and a ROC curve was generated to identify the CAT score that best concorded with the mMRC scale. RESULTS: The concordance for the GOLD groups classified by CAT and mMRC was moderate (kappa 0.492). For mMRC score of 1 and 2, a CAT score of ≥9 and ≥16 showed the maximum value of the Youden index, respectively. By reclassifying the patients with the new cut-off points obtained, the best concordance was obtained between the cut-off point for CAT of 16 and for mMRC of 2, followed by CAT of 9 and mMRC of 1. CONCLUSION: Because of the deficient concordance between CAT and mMRC, we propose the use of new cut-off points in future updates of the GOLD strategy. |
format | Online Article Text |
id | pubmed-7430767 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-74307672020-08-25 Variation in Assignment of the COPD Patients into a GOLD Group According to Symptoms Severity Moya-Álvarez, Virginia Quevedo-Marín, Juan Luis Ji, Zichen Navarro-Jiménez, Cristina Jiménez-García, Rodrigo López-de-Andrés, Ana Pérez-Trullén, Alfonso de Miguel-Díez, Javier Int J Chron Obstruct Pulmon Dis Original Research INTRODUCTION: The Global Organization of Lung Disease (GOLD) classifies patients with chronic obstructive pulmonary disease (COPD) taking into account the symptoms. The modified Medical Research Council’s dyspnea scale (mMRC) and the COPD assessment test (CAT) are used to assess these symptoms. In this study, we analyze the concordance of GOLD classification using mMRC and CAT. PATIENTS AND METHODS: This is an observational study of a cohort of 169 patients with COPD, who were classified following the GOLD 2017 recommendations, using both mMRC and CAT. A concordance analysis was applied, and a ROC curve was generated to identify the CAT score that best concorded with the mMRC scale. RESULTS: The concordance for the GOLD groups classified by CAT and mMRC was moderate (kappa 0.492). For mMRC score of 1 and 2, a CAT score of ≥9 and ≥16 showed the maximum value of the Youden index, respectively. By reclassifying the patients with the new cut-off points obtained, the best concordance was obtained between the cut-off point for CAT of 16 and for mMRC of 2, followed by CAT of 9 and mMRC of 1. CONCLUSION: Because of the deficient concordance between CAT and mMRC, we propose the use of new cut-off points in future updates of the GOLD strategy. Dove 2020-08-12 /pmc/articles/PMC7430767/ /pubmed/32848383 http://dx.doi.org/10.2147/COPD.S253445 Text en © 2020 Moya-Álvarez et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Moya-Álvarez, Virginia Quevedo-Marín, Juan Luis Ji, Zichen Navarro-Jiménez, Cristina Jiménez-García, Rodrigo López-de-Andrés, Ana Pérez-Trullén, Alfonso de Miguel-Díez, Javier Variation in Assignment of the COPD Patients into a GOLD Group According to Symptoms Severity |
title | Variation in Assignment of the COPD Patients into a GOLD Group According to Symptoms Severity |
title_full | Variation in Assignment of the COPD Patients into a GOLD Group According to Symptoms Severity |
title_fullStr | Variation in Assignment of the COPD Patients into a GOLD Group According to Symptoms Severity |
title_full_unstemmed | Variation in Assignment of the COPD Patients into a GOLD Group According to Symptoms Severity |
title_short | Variation in Assignment of the COPD Patients into a GOLD Group According to Symptoms Severity |
title_sort | variation in assignment of the copd patients into a gold group according to symptoms severity |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430767/ https://www.ncbi.nlm.nih.gov/pubmed/32848383 http://dx.doi.org/10.2147/COPD.S253445 |
work_keys_str_mv | AT moyaalvarezvirginia variationinassignmentofthecopdpatientsintoagoldgroupaccordingtosymptomsseverity AT quevedomarinjuanluis variationinassignmentofthecopdpatientsintoagoldgroupaccordingtosymptomsseverity AT jizichen variationinassignmentofthecopdpatientsintoagoldgroupaccordingtosymptomsseverity AT navarrojimenezcristina variationinassignmentofthecopdpatientsintoagoldgroupaccordingtosymptomsseverity AT jimenezgarciarodrigo variationinassignmentofthecopdpatientsintoagoldgroupaccordingtosymptomsseverity AT lopezdeandresana variationinassignmentofthecopdpatientsintoagoldgroupaccordingtosymptomsseverity AT pereztrullenalfonso variationinassignmentofthecopdpatientsintoagoldgroupaccordingtosymptomsseverity AT demigueldiezjavier variationinassignmentofthecopdpatientsintoagoldgroupaccordingtosymptomsseverity |